The abstract is read at the publisher; the summary is JClub's.
The MOBILE platform uses triphylite (LiFePO4) as a bioelectronic electrode to enable near-binary ON/OFF switching and highly localized Li+ generation for precise neural inhibition.
- Why it matters: Molecularly specific, fully electronic control of bioactivity with high precision is difficult, and systemic lithium dosing risks side effects.
- What they did: The authors build MOBILE from an electroactive solid-state inorganic cathode (LiFePO4), using direct photopatterning to adapt it for bioelectronic devices and to localize lithium electrochemistry in biofluids.
- The result: In both peripheral and central nervous system settings, localized Li+ production achieves effective inhibition, potentially lowering lithium dosages versus conventional systemic lithium therapies and supporting pain-relief applications.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.